News

PharmiWeb4h
A New Era of Healthcare: Desert Oasis Healthcare Unveils Cutting-Edge AI Solutions
DOHC Launches AI Innovations to Improve Healthcare Access and Accuracy PALM SPRINGS, CA / ACCESS Newswire / April 9, 2025 / Desert Oasis Healthcare (DOHC) is proud to announce its pioneering use of ...
PharmiWeb6h
Research finds tablet could slow progress of Alzheimer's disease over 18-month period
Researchers have reported a potential oral treatment for Alzheimer’s disease that slowed its progression over a period of at least 18 months. Developed by Singaporean company TauRx Pharmaceutics Ltd, ...
PharmiWeb6h
AMRC welcomes Pratia as newest member, strengthening European representation
The Association of Multisite Research Corporations (AMRC) today announces Pratia, one of the largest and most respected site networks, has joined as the association’s fifteenth member. With this ...
PharmiWeb6h
Oxolife’s CEO Agnès Arbat receives prestigious EU Women Innovators Prize
Oxolife, the female fertility biotech focused on increasing live birth rates by enhancing embryo implantation in women undergoing assisted reproductive technology (ART) fertility treatment, today ...
PharmiWeb7h
BRK Technology Driving Sustainability With Algae Biofuels
BRK Technology empowers companies to lower their carbon footprints by adopting algae biofuels for cleaner, renewable energy ...
PharmiWeb7h
SpendMend Achieves HITRUST i1 Certification to Manage Data Protection and Mitigate Cybersecurity Threats
HITRUST certification validates that SpendMend is operating with leading security practices to protect sensitive information. GRAND RAPIDS, MICHIGAN / ACCESS Newswire / April 9, 2025 / SpendMend, a ...
PharmiWeb7h
Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Dr. Reid Bissonnette, Executive Consultant for Translational Research and Development at Xenetic, discusses positive preclinical data recently presented at the Society for Immunotherapy of Cancer ...
PharmiWeb8h
Heart Pump Device Market Poised for Significant Growth Amidst Rising Cardiovascular Disease Prevalence and Technological Advancements
Heart Pump Device MarketThe global Heart Pump Device Market is expected to rise from USD 4.0 billion in 2024 to USD 25.4 ...
PharmiWeb9h
Brainomix Advances Stroke Care with Landmark FDA Clearance
Brainomix, a global leader in AI-powered stroke imaging, has announced the FDA clearance of a novel and patented feature that ...
PharmiWeb10h
Infinitopes Granted Phase I/IIa Clinical Trial Application Approval to Evaluate Precision Vaccine Targeting Early-Stage Oesophageal Cancer
Infinitopes Ltd today announces that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted Clinical Trial Application (CTA) approval for the first-in-human Phase I/IIa clinical ...
PharmiWeb10h
Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
The New England Journal of Medicine (NEJM) published positive results from the HERCULES phase 3 study demonstrating that tolebrutinib delayed disability progression in people with non-relapsing ...
PharmiWeb10h
ValoTx Appoints Marcella Origgi from Johnson & Johnson Innovation as CEO
Valo Therapeutics Oy (ValoTx), an immunotherapy company developing novel, adaptable treatments for cancer, today announced the appointment of Marcella Origgi as its Chief Executive Officer (CEO) of ...